Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN; NYSE: SNN) will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.

The ACTICOAT range of antimicrobial dressings helps in the management of wounds at risk for infection.  The antimicrobial properties last up to seven days meaning fewer dressing changes. The launch of the ACTICOAT Flex 7 Ribbon and ACTICOAT Post-Op 4x13 3/4 wound dressings extend Smith & Nephew's unique range of antimicrobial barrier dressings for use in chronic and acute wounds. The ACTICOAT portfolio utilizes Nanocrystalline silver technology to provide an effective barrier to more than 150 wound pathogens, including 188 strains of MRSA.

"ACTICOAT post op dressings may help manage the risk of post surgical infection, and the new longer size will work well for procedures associated with hip, ankle and tibial plateau fractures," said Dr. Michael Suk, Associate Professor and Division Chief, Orthopaedic Trauma, University of Florida – Shands Jacksonville.  "The conformability of the ACTICOAT Flex 7 Ribbon makes it a good choice for cavity wounds which may be difficult to dress."

"One of the core strategies of Smith & Nephew is putting the customer first. The new ACTICOAT line extensions were designed based on the demanding clinical needs of surgeons and wound care professionals," said Tom Dugan, North American President, Smith & Nephew Advanced Wound Management. "We will continue to listen to feedback from our customers in order to provide cost effective products that optimize wound care in their practice, drive value for healthcare providers, and enhance patient safety, quality and comfort."